What it's for (Indications)
- Cinnarizine + sodium cromoglycate is indicated for the symptomatic treatment and prophylaxis of allergic conditions, particularly those affecting the respiratory system and vestibular apparatus.
- This includes conditions such as allergic rhinitis, characterized by symptoms like sneezing, rhinorrhea, nasal congestion, and itching, especially when associated with co-existing vestibular symptoms such as dizziness or vertigo.
- It may also be considered in the management of Meniere's disease or other labyrinthine disorders where an allergic or inflammatory component is suspected, providing both anti-allergic and anti-vertigo effects.
- The combination aims to offer relief from acute allergic symptoms and vestibular disturbances while also providing a prophylactic effect against the release of inflammatory mediators.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The precise dosage of cinnarizine + sodium cromoglycate is highly dependent on the specific formulation (e.g., oral tablet, nasal spray) and the clinical indication, as well as patient-specific factors such as age, weight, and renal/hepatic function. For oral formulations, typical adult doses of cinnarizine often range from 25mg to 75mg daily, divided into multiple doses. Sodium cromoglycate, when administered orally, is typically dosed in higher amounts for systemic conditions like mastocytosis, but if formulated for synergistic effects in this combination, its dose would be carefully optimized. For nasal spray formulations, specific numbers of actuations per nostril, usually multiple times daily, would be prescribed. Pediatric dosing requires careful adjustment and strict medical supervision. Always refer to the manufacturer's prescribing information and consult a healthcare professional for individualized dosage recommendations to ensure optimal therapeutic effect and minimize adverse events. |
Safety & Warnings
Common Side Effects
- Common side effects associated with cinnarizine + sodium cromoglycate can stem from either component.
- Cinnarizine commonly causes drowsiness or sedation, particularly at the initiation of treatment or at higher doses, which can impair ability to drive or operate machinery.
- Other cinnarizine-related side effects include gastrointestinal disturbances such as nausea, indigestion, and dry mouth.
- Less common but reported effects include headache, dizziness (paradoxically, despite its anti-vertigo effect), and allergic skin reactions.
- Sodium cromoglycate, especially in topical formulations, can cause local irritation, sneezing, nasal stinging or burning, epistaxis (nosebleeds), and a bitter taste.
- Systemic absorption of sodium cromoglycate is generally low, minimizing systemic side effects, but hypersensitivity reactions are possible.
- Patients should be advised to report any persistent or severe side effects to their healthcare provider for evaluation.
- The combination may intensify sedative effects due to cinnarizine.
Serious Warnings
- Black Box Warning: While cinnarizine + sodium cromoglycate does not typically carry an official FDA-style Black Box Warning, several serious warnings and precautions must be rigorously observed. Patients should be explicitly cautioned about the significant potential for drowsiness, sedation, and impairment of psychomotor skills, particularly during the initial phases of treatment. These effects can be dangerously potentiated by concomitant use of alcohol, other central nervous system depressants (e.g., sedatives, anxiolytics, opioids), or certain antidepressants. Patients must be advised against operating heavy machinery, driving a vehicle, or engaging in activities requiring high levels of mental alertness until they fully understand how the medication affects them. In elderly patients, there is an increased risk of severe sedation, cognitive impairment, and paradoxical reactions, including confusion or excitation; therefore, careful dosage adjustment and monitoring are essential. Long-term use of cinnarizine, especially in elderly individuals, has been associated with the development or exacerbation of parkinsonism-like symptoms, necessitating careful neurological assessment and discontinuation if such symptoms arise. Any signs of severe allergic reactions, including anaphylaxis, require immediate medical attention.
- Patients should be advised that cinnarizine, a component of this combination, can cause drowsiness or sedation, which may be exacerbated by alcohol or other CNS depressants.
- Therefore, caution is advised when operating machinery or driving vehicles.
- Patients with glaucoma, prostatic hypertrophy, or conditions aggravated by anticholinergic effects should use this medication with caution due to the antihistaminic properties of cinnarizine.
- Special care is necessary in elderly patients, who may be more susceptible to sedative effects and paradoxical excitation.
- Renal or hepatic impairment may require dose adjustments due to altered metabolism and excretion of cinnarizine.
- While sodium cromoglycate has a generally favorable safety profile, it should not be used for acute relief of bronchospasm or other immediate allergic reactions.
- Rare but serious hypersensitivity reactions, including anaphylaxis, can occur with either component.
- Patients with a history of cardiac arrhythmias or porphyria should use cinnarizine with caution.
- Regular medical follow-up is recommended to monitor efficacy and safety, especially during prolonged use, to prevent potential adverse outcomes and ensure optimal patient management.
How it Works (Mechanism of Action)
Cinnarizine + sodium cromoglycate combines two distinct pharmacological agents to exert its therapeutic effects. Cinnarizine is an antihistamine, specifically an H1-receptor blocker, which antagonizes the effects of histamine, thereby reducing allergic symptoms such as sneezing, itching, and rhinorrhea. Additionally, cinnarizine acts as a calcium channel blocker, primarily affecting the vestibular system. It inhibits calcium influx into vestibular sensory cells, leading to a reduction in labyrinthine excitability and improving symptoms of vertigo, dizziness, and motion sickness. Sodium cromoglycate, on the other hand, is a mast cell stabilizer. It works by inhibiting the degranulation of mast cells, thereby preventing the release of various inflammatory mediators, including histamine, leukotrienes, and prostaglandins, which are crucial in initiating and perpetuating allergic responses. This prophylactic action helps to prevent the onset of allergic symptoms rather than just treating them. The synergistic combination provides both symptomatic relief from existing allergic and vestibular issues and a preventive effect against further allergic reactions.
Commercial Brands (Alternatives)
No other brands found for this formula.